Phenobarbital Concentration-Targeted Supplemental Dose: Clinical Pharmacology Guide

Overview

Calculates a supplemental phenobarbital amount required to move from a measured concentration to a selected target using an apparent distribution volume.

Clinical Significance

This calculation estimates an amount in the apparent distribution space; it is not a prescribing recommendation.

When to Use

• Use when the required concentration, timing and dosing information are reliable and the stated pharmacokinetic assumptions are reasonable.
• Use within an approved therapeutic-drug-monitoring or medicines-governance pathway.
• Use to support transparent review, not to automate prescribing.

How It Is Calculated

• Supplemental amount = (target − measured concentration) × Vd × weight.
• MedicalC validates that all required inputs are numeric and rejects internally impossible time or concentration relationships where applicable.

Interpretation

• This calculation estimates an amount in the apparent distribution space; it is not a prescribing recommendation.
• Interpret the result with the clinical indication, microbiology or seizure control, organ function, assay timing and local targets.

Worked Example

Enter a verified set of source values in the displayed units. MedicalC applies: Supplemental amount = (target − measured concentration) × Vd × weight. Recheck the source chart and sampling times before using the result.

Patient Considerations

• Use only within specialist adult or paediatric protocols. Altered distribution and clearance in neonates, pregnancy, obesity and organ failure require expert interpretation.
• Consider acute kidney injury, augmented renal clearance, fluid shifts, obesity, burns, pregnancy, critical illness and interacting medicines.

Limitations

• One-compartment equations may not describe distribution or multicompartment behaviour accurately.
• Derived values can appear precise despite uncertainty in sampling time, assay result and clearance stability.
• A calculated exposure or dose does not establish clinical benefit or safety.

Clinical Pearls

• A low concentration does not automatically justify supplementation when seizure control is adequate or toxicity is clinically present.
• Plot concentrations against actual elapsed time before accepting any pharmacokinetic slope.
• When the result conflicts with the patient, verify the data rather than forcing a dose change.

Common Mistakes

• Using scheduled rather than actual administration and blood-sampling times.
• Treating a level drawn during distribution as a post-distribution concentration.
• Mixing mg/L, micrograms/mL and micrograms/L.
• Applying steady-state equations before steady state or during changing clearance.
• Using a generic concentration target outside the relevant indication or local protocol.

Evidence Base

Principal source: Patsalos PN, et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring. Epilepsia. 2008.

References

1. Patsalos PN, et al. Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring. Epilepsia. 2008. — Primary publication, consensus guideline or authoritative pharmacokinetic source.